Literature DB >> 34196322

Ocular Inflammation and Treatment Emergent Adverse Events in Retinal Gene Therapy.

Neesurg Mehta, Deborah A Robbins, Glenn Yiu.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34196322      PMCID： PMC8259781          DOI： 10.1097/IIO.0000000000000366

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN： 0020-8167


× No keyword cloud information.
  119 in total

1.  Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta.

Authors:  G A Wilbanks; M Mammolenti; J W Streilein
Journal:  Eur J Immunol       Date:  1992-01       Impact factor: 5.532

2.  Toll-like receptor 2-mediated innate immune response in human nonparenchymal liver cells toward adeno-associated viral vectors.

Authors:  Marianna Hösel; Mathias Broxtermann; Hanna Janicki; Knud Esser; Silke Arzberger; Pia Hartmann; Sonja Gillen; Jörg Kleeff; Dirk Stabenow; Margarete Odenthal; Percy Knolle; Michael Hallek; Ulrike Protzer; Hildegard Büning
Journal:  Hepatology       Date:  2012-01       Impact factor: 17.425

3.  Characterization of the choroid-scleral junction and suprachoroidal layer in healthy individuals on enhanced-depth imaging optical coherence tomography.

Authors:  Glenn Yiu; Paula Pecen; Neeru Sarin; Stephanie J Chiu; Sina Farsiu; Prithvi Mruthyunjaya; Cynthia A Toth
Journal:  JAMA Ophthalmol       Date:  2014-02       Impact factor: 7.389

4.  Safety and Long-Term Efficacy of AAV4 Gene Therapy in Patients with RPE65 Leber Congenital Amaurosis.

Authors:  Guylène Le Meur; Pierre Lebranchu; Fanny Billaud; Oumeya Adjali; Sébastien Schmitt; Stéphane Bézieau; Yann Péréon; Romain Valabregue; Catherine Ivan; Christophe Darmon; Philippe Moullier; Fabienne Rolling; Michel Weber
Journal:  Mol Ther       Date:  2017-09-19       Impact factor: 11.454

5.  CD8(+) T-cell responses to adeno-associated virus capsid in humans.

Authors:  Federico Mingozzi; Marcela V Maus; Daniel J Hui; Denise E Sabatino; Samuel L Murphy; John E J Rasko; Margaret V Ragni; Catherine S Manno; Jurg Sommer; Haiyan Jiang; Glenn F Pierce; Hildegund C J Ertl; Katherine A High
Journal:  Nat Med       Date:  2007-03-18       Impact factor: 53.440

Review 6.  Adeno-associated viral vector-mediated immune responses: Understanding barriers to gene delivery.

Authors:  Natalie F Nidetz; Michael C McGee; Longping V Tse; Chengwen Li; Le Cong; Yunxing Li; Weishan Huang
Journal:  Pharmacol Ther       Date:  2019-12-11       Impact factor: 12.310

7.  Distinct immune responses to transgene products from rAAV1 and rAAV8 vectors.

Authors:  Yuanqing Lu; Sihong Song
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-22       Impact factor: 11.205

8.  Adeno-associated virus capsid structure drives CD4-dependent CD8+ T cell response to vector encoded proteins.

Authors:  Lauren E Mays; Luk H Vandenberghe; Ru Xiao; Peter Bell; Hyun-Joo Nam; Mavis Agbandje-McKenna; James M Wilson
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

9.  Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular Degeneration.

Authors:  Ian J Constable; Cora M Pierce; Chooi-May Lai; Aaron L Magno; Mariapia A Degli-Esposti; Martyn A French; Ian L McAllister; Steve Butler; Samuel B Barone; Steven D Schwartz; Mark S Blumenkranz; Elizabeth P Rakoczy
Journal:  EBioMedicine       Date:  2016-11-10       Impact factor: 8.143

10.  Overcoming preexisting humoral immunity to AAV using capsid decoys.

Authors:  Federico Mingozzi; Xavier M Anguela; Giulia Pavani; Yifeng Chen; Robert J Davidson; Daniel J Hui; Mustafa Yazicioglu; Liron Elkouby; Christian J Hinderer; Armida Faella; Carolann Howard; Alex Tai; Gregory M Podsakoff; Shangzhen Zhou; Etiena Basner-Tschakarjan; John Fraser Wright; Katherine A High
Journal:  Sci Transl Med       Date:  2013-07-17       Impact factor: 17.956
View more
  3 in total

Review 1.  Review of gene therapies for age-related macular degeneration.

Authors:  Arshad M Khanani; Mathew J Thomas; Aamir A Aziz; Christina Y Weng; Carl J Danzig; Glenn Yiu; Szilárd Kiss; Nadia K Waheed; Peter K Kaiser
Journal:  Eye (Lond)       Date:  2022-01-11       Impact factor: 4.456

Review 2.  Ocular Barriers and Their Influence on Gene Therapy Products Delivery.

Authors:  Bastien Leclercq; Dan Mejlachowicz; Francine Behar-Cohen
Journal:  Pharmaceutics       Date:  2022-05-06       Impact factor: 6.525

Review 3.  Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses.

Authors:  Hashem H Ghoraba; Amir Akhavanrezayat; Irmak Karaca; Negin Yavari; Sherin Lajevardi; Jaclyn Hwang; Jonathan Regenold; Wataru Matsumiya; Brandon Pham; Moosa Zaidi; Azadeh Mobasserian; Anthony Toan DongChau; Christopher Or; Cigdem Yasar; Kapil Mishra; Diana Do; Quan Dong Nguyen
Journal:  Clin Ophthalmol       Date:  2022-06-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.